LDS/Medical Tests/General Health Panel

General Health Panel

The General Health Panel is utilized by the physician to diagnose illness or to help monitor the patient’s response to treatment. GHP provides a general look at the patient’s wellbeing. The GHP is performed most commonly during normal health screenings or when a disease is suspected in order to obtain general information that may be useful in diagnosis. The most common tests included in this panel are Complete Blood Count (CBC), Complete Metabolic Panel (CMP), and Thyroid Stimulating Hormone (TSH). It is commonly ordered at an annual physical examination or checkup, as supportive diagnostic testing for a wide range of diseases and syndromes, for disease management, therapy monitoring, and patient safety during therapy, and during any medical intervention and post-therapy as well as drug side effect monitoring.

Any abnormal results in any of these tests or in combination may provide an important initial indication of a disease state; the differential diagnosis of that state might then indicate more specialized testing to be ordered. Because this panel contains the main metabolic monitoring tests, this panel usually provides an important screening check on the status of kidney and kidney function, liver and liver function, heart and heart status, electrolyte and body fluid balance, and other body systems.

It is routinely used to monitor the status of a patient with a chronic disease such as a chronic autoimmune disease, diabetes mellitus, hypertension, cancer, chronic infection, and inflammation.

This test does not meet "medical necessity" so labs need to “unbundle” the group of tests to make them billable.

  • Since this panel has a broad use, we list here only the major utilities of this panel:
  • As an aid in diagnosis of chronic diseases (autoimmune diseases, diabetes etc.)
  • Inflammation
  • Infections
  • Blood disorders
  • Kidney diseases
  • Urinary tract diseases
  • Liver diseases
  • Gastrointestinal diseases
  • Cardiovascular system disorders
  • Heart disease
  • Hypertension
  • Bone diseases
  • Muscle disorders
  • Cancers
  • Congenital disorders
  • Genetic disorders
  • Use as a screening test for physical evaluation
  • Disease management and therapy monitoring
  • Safety monitoring during therapy
  • Supportive testing for many medical interventions

Abnormal results (both increases and decreases) of one or more can be significant and might indicate the need for additional disease or disorder specialized testing.

  • Chronic diseases (autoimmune diseases, diabetes)
  • Inflammation
  • Trauma and burns
  • Infections
  • Blood disorders
  • Kidney diseases
  • Liver diseases
  • Gastrointestinal diseases
  • Cardiovascular system disorders
  • Disease related to the heart
  • Hypertension
  • Bone diseases
  • Muscle disorders
  • Cancer
  • Congenital disorders
  • Genetic disorders
  • Pancreatic diseases
  • Storage disorders
  • Surgery
  • Pregnancy
  • Poisoning
  • Enzyme metabolic diseases
  • Myeloproliferative disorders
  • Hemoconcentration due to dehydration
  • Anemia
  • Bleeding
  • Hemolytic anemias
  • Spurious decrease with autoagglutination (e.g., cold agglutinins)

Note: for more information see individual test utility and interpretation.

Uric Acid (Blood):

            3.0 and 7.0 mg/dL

Uric Acid (Urine):

            250-800 mg/24 hours

Thyroid-Stimulating Hormone (TSH):

            0.4 - 4.0 mIU/L

Lactate Dehydrogenase (LDH):

            105 - 333 IU/L

Gamma-Glutamyl Transpeptidase (GGT):

            0-51 IU/L

 

Complete Blood Count (CBC):

            WBC: 4.5-11 x 103 cells/mm3

            RBC: 4.5-5.9 x 106/mm3 (male)

                     4-5.2 x 106/mm3 (female)

            MCV: 80-100 mcm3

            MCHC: 31-37 g/dL

            Hgb: 13.5-17.5 g/dL (male)

                     12-16 g/dL (female)

            Hct: 41%-53% (male)

                   36%-46% (female)

            Platelet Count: 150-350 × 103 /mm3

 

Differential Blood Count:

            Neutrophils: 3150 to 6200/uL

            Lymphocytes: 1500 to 3000/uL

            Monocytes: 300 to 500/uL

            Eosinophils: 50 to 250/uL

            Basophils: 15 to 50/uL

 

 

See individual test or panel for more information.

Serum (SST), Plasma (EDTA). 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Additional disease specific/supportive testing if indicated. If one or more are abnormal (increased or decreased) see individual test. In addition to disease specific, here are some common tests to follow up abnormal tests of this panel: Acute Viral Hepatitis Panel (Hepatitis C, Hepatitis B, and Hepatitis A antibody testing), Liver Profile, CKMB, CK Isoenzymes, Alkaline Phosphatase Isoenzymes, C-reactive Protein, Protein Electrophoresis, Immunoglobulins, Blood Lead Levels, Complement Proteins (C3, C4), JAK2 mutation for Polycythemia vera diagnosis if suspected, Serum Iron, TIBC, Ferritin.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login